Patent Assignment
Reel/Frame 034872/0894
Assignment of Assignor's Interest
Recorded: 2015-02-02
Pages: 16
Assignor
TEGO BIOSCIENCES CORPORATION
Executed: 2010-06-11
Assignee
LUNA INNOVATIONS INCORPORATED
1 RIVERSIDE CIRCLE, SUITE 400, ROANOKE, VIRGINIA, 24016
Covered Properties
(43)
Multiply-Substituted Fullerenes and Methods for Their Preparation and Characterization
Application:
08/509,209 →
Multi-Substituted Fullerenes and Methods for Their Preparation and Characterization
Patent:
6,162,926 →
Application:
08/969,261 →
Tumor treatment
Application:
09/666,989 →
Multiply-substituted fullerenes and methods for their preparation
Patent:
6,399,785 →
Application:
09/702,143 →
Multiply-Substituted Fullerenes and Methods for Their Preparation and Characterization
Patent:
6,448,412 →
Application:
09/702,144 →
Multioligoanilinated Fullerenes
Patent:
6,452,037 →
Application:
09/840,323 →
Water-soluble dendrimeric fullerene as anti-HIV therapeutic
Application:
09/853,202 →
Publication:
US 2003/0036562
Method of Synthesis of Water Soluble Fullerene Polyacids Using a Macrocyclic Malonate Reactant
Patent:
6,538,153 →
Application:
09/962,492 →
Fullerene (C60) -Based X-Ray Contrast Agent for Diagnostic Imaging
Fullerene-based drugs targeted to bone
Application:
10/258,774 →
Publication:
US 2004/0038946
Use of Buckysome or Carbon Nanotube for Drug Delivery
Fullerenes in targeted therapies
Application:
10/623,190 →
Use of buckysome or carbon nanotube for drug delivery
Application:
10/790,153 →
Publication:
US 2004/0166152
Fullerene compositions for ameliorating dermatological conditions
Application:
10/822,644 →
Publication:
US 2005/0058675
Substituted Fullerene Compositions and Their Use as Antioxidants
Amphiphilic [5:1]- and [3:3]- Hexakisadducts of Fullerenes
Substituted fullerenes and their use as inhibitors of cell death
Application:
11/120,168 →
Publication:
US 2006/0247152
Substituted fullerene formulations and their use in ameliorating oxidative stress diseases or inhibiting cell death
Application:
11/158,915 →
Publication:
US 2005/0288236
Method of synthesis of water soluble fullerene polyacids using a malonate reactant
Application:
11/214,468 →
Publication:
US 2006/0047167
Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis
Application:
11/214,469 →
Publication:
US 2006/0047003
Substituted fullerene compositions and their use as antioxidants
Application:
11/256,359 →
Publication:
US 2006/0040938
Substituted Fullerene Compositions and Their Use in Treatment of Shock
Application:
11/334,579 →
Publication:
US 2006/0198813
Use of Fullerenes to Oxidize Reduced Redox Proteins
Application:
11/561,520 →
Publication:
US 2008/0020977
Use of Carbon Nanotube for Drug Delivery
Application:
11/841,087 →
Publication:
US 2008/0193490
Substituted Fullerenes and Their Use as Inhibitors of Cell Death
Application:
12/422,659 →
Publication:
US 2009/0197950
Substituted Fullerene Formulations and Their Use in Ameliorating Oxidative Stress Diseases or Inhibiting Cell Death
Application:
12/422,678 →
Publication:
US 2009/0197951
Fullerene-based drugs targeted to bone
Application:
60/199,970 →
Fullerene (C60)-based X-ray contrast agents for diagnostic imaging
Application:
60/247,337 →
Use of buckysome or carbon nanotube for drug delivery
Application:
60/356,856 →
Fullerenes for targeted therapies
Application:
60/398,325 →
Fullerene compositions for treating dermatological conditions
Application:
60/461,914 →
Antioxidant metallofullerene compositions
Application:
60/488,062 →
Substituted fullerenes as antioxidants
Application:
60/510,283 →
Substituted fullerenes and their use as antioxidants
Application:
60/510,455 →
Substituted fullerenes and their use as antioxidants
Application:
60/510,598 →
Amphiphilic and hexakisadducts of C60
Application:
60/511,763 →
Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis
Application:
60/606,779 →
Method of synthesis of water soluble fullerene polyacids using a malonate reactant
Application:
60/606,780 →
Substituted fullerene compositions and their use in treatment of shock
Application:
60/644,911 →
Regioselective synthesis and zone selective deprotection of [60]fullerene trisadducts with an e,e,e, addition pattern
Application:
60/668,230 →
Use of fullerenes to oxidize reduced redox proteins
Application:
60/738,486 →
Substituted Fullerenes as MRI Contrast Agents
Application:
61/038,110 →
Substituted Fullerenes as MRI Contrast Agents
Application:
61/049,002 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jan 14, 2010
From: LUNA INNOVATIONS INCORPORATED
To: HANSEN MEDICAL, INC.
Reel/Frame 023792/0388 →
Security Agreement
Feb 25, 2010
From: LUNA INNOVATIONS INCORPORATED
To: SILICON VALLEY BANK
Reel/Frame 023985/0718 →
Release of Security Interest
Dec 9, 2013
From: HANSEN MEDICAL, INC.
To: LUNA INNOVATIONS INCORPORATED
Reel/Frame 031784/0755 →
Release of Security Interest
Feb 6, 2015
From: HANSEN MEDICAL, INC.
To: LUNA INNOVATIONS INCORPORATED
Reel/Frame 034914/0407 →
Security Interest
Mar 4, 2021
From: LUNA INNOVATIONS INCORPORATED; FORMER LUNA SUBSIDIARY, INC.; GENERAL PHOTONICS CORP.
To: PNC BANK, NATIONAL ASSOCIATION
Reel/Frame 056455/0331 →
Assignment of Assignor's Interest
Feb 26, 2022
From: LUNA INNOVATIONS INCORPORATED
To: LUNA LABS USA, LLC
Reel/Frame 059109/0181 →
Security Interest
Mar 9, 2022
From: LUNA LABS USA, LLC
To: M&T BANK
Reel/Frame 059211/0861 →
Release of Security Interest
Mar 25, 2022
From: PNC BANK, NATIONAL ASSOCIATION
To: LUNA LABS USA, LLC
Reel/Frame 059396/0791 →
Release of Security Interest
Jan 29, 2026
From: M&T BANK
To: LUNA LABS USA, LLC
Reel/Frame 073628/0060 →